June 15, 2020 / 10:39 PM / 21 days ago

BRIEF-FDA Warns Against Combination Of Chloroquine Phosphate Or Hydroxychloroquine Sulfate & Remdesivir

June 15 (Reuters) - FDA:

* FDA WARNS OF NEWLY DISCOVERED POTENTIAL DRUG INTERACTION THAT MAY REDUCE EFFECTIVENESS OF A COVID-19 TREATMENT AUTHORIZED FOR EMERGENCY USE

* FDA - WARNING HEALTH CARE PROVIDERS ABOUT NEWLY DISCOVERED POTENTIAL DRUG INTERACTION RELATED TO REMDESIVIR

* FDA - CO-ADMINISTRATION OF REMDESIVIR & CHLOROQUINE PHOSPHATE OR HYDROXYCHLOROQUINE SULFATE IS NOT RECOMMENDED

* FDA - CO-ADMINISTRATION MAY RESULT IN IN REDUCED ANTIVIRAL ACTIVITY OF REMDESIVIR Source text: bit.ly/3hA6JxQ Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below